论文信息 - Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis - 字舞流文

Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis

K. Takehara | A. Yachie | M. Shimizu | T. Yokoyama | K. Ohta | Yuko Nakayama | Y. Hashida | T. Saito | K. Ueno | Takekatsu Saito

[1] E. Rosato,et al. Bosentan Improves Skin Perfusion of Hands in Patients with Systemic Sclerosis with Pulmonary Arterial Hypertension , 2010, The Journal of Rheumatology.

[2] M. Mayes,et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial , 2010, Annals of the rheumatic diseases.

[3] M. Humbert,et al. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil. , 2010, Rheumatology.

[4] R. Russo,et al. Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center , 2007, Pediatric rheumatology online journal.

[5] P. Woo,et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. , 2006, Arthritis and rheumatism.

[6] A. Hislop,et al. Response to bosentan in children with pulmonary hypertension , 2005, Heart.

[7] A. Branzi,et al. The endothelin system in pulmonary arterial hypertension. , 2004, Cardiovascular research.

[8] Avid,et al. BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION , 2002 .

[9] N. Suzuki,et al. Significance of plasma endothelin-1 levels in patients with systemic sclerosis. , 1992, The Journal of rheumatology.